4.2 Article

SDF-1 and CXCR4 in synovium are associated with disease activity and bone and joint destruction in patients with rheumatoid arthritis treated with golimumab

Related references

Note: Only part of the references are listed.
Article Rheumatology

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics

Glynn Dennis et al.

ARTHRITIS RESEARCH & THERAPY (2014)

Article Endocrinology & Metabolism

Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma-Associated Bone Loss

Peter Diamond et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2009)

Review Rheumatology

Cells of the synovium in rheumatoid arthritis - T lymphocytes

Steven K. Lundy et al.

ARTHRITIS RESEARCH & THERAPY (2007)

Review Rheumatology

Cells of the synovium in rheumatoid arthritis - Macrophages

Raimund W. Kinne et al.

ARTHRITIS RESEARCH & THERAPY (2007)